On June 15, 2026, Nano Dimension Ltd. entered into a non-binding term sheet to acquire Infinite Epigenetics, Inc. in an all-stock transaction. The valuation of Infinite is set at $890 million, less a premium based on Nano's net cash. Nano's valuation for the exchange ratio will include 100% of its net cash plus a 20% premium, an estimated $20 million for Essemtec, and other remaining assets. The combined company's board will consist of seven members, with Infinite designating four or five members depending on their final ownership percentage. Nano may reimburse Infinite up to $3 million in expenses if a definitive agreement is not reached by the next Extraordinary General Meeting. The agreement includes a 30-day exclusivity period. Nano Dimension operates in the additive manufacturing and electronics industry, providing 3D printing solutions.
